Comparison 19. Hyalgan versus Hyalgan.
Outcome or subgroup title | No. of studies | No. of participants | Statistical method | Effect size |
---|---|---|---|---|
1 Patient global (number of patients assessing response as satisfactory) | 1 | Risk Ratio (M‐H, Fixed, 95% CI) | Subtotals only | |
1.1 45 to 52 weeks post‐injection | 1 | 159 | Risk Ratio (M‐H, Fixed, 95% CI) | 0.85 [0.70, 1.03] |